De Novo Facioscapulohumeral Muscular Dystrophy
Background and Objectives Facioscapulohumeral muscular dystrophy (FSHD) includes approximately 10%–30% sporadic cases, where de novo pathogenic variants are hypothesized to be associated with more severe phenotypes. However, the systematic clinical characteristics and natural history of these cases remain poorly define...